In this issue:
Risk of VTE in patients with gastrointestinal cancer
Safety not improved with apixaban vs VKA in patients on chronic haemodialysis
Long-term anti-CD20 therapy effective for ADAMTS13 relapse in iTTP
SCT reduces vaso-occlusive events in patients with sickle cell disease
Diverse pattern of autoantibodies found in acquired haemophilia
Caplacizumab reduces exacerbation and refractoriness in iTTP
Surgery safe in patients with haemophilia A receiving emicizumab
ABO blood group type and risk of VTE in patients with cancer
Cost-effectiveness of secondline therapies for ITP
Pre-emptive cyclosporin A in iTTP refractory to rituximab
Please login below to download this issue (PDF)